Dr. Erhan Bas

Biography

 Bilim Pharmaceuticals currently exports to 58 countries, a number which grew by six since last year. Today, we are present in regions ranging from South America to Far Asia. Annually, we have consistently realized double-digit growth for our foreign market sales. For expanding our global footprint, Bilim Pharmaceuticals targets two markets in particular in the near-term: Russia and Vietnam. These markets will see the strongest growth globally. Our entry into them is part of a larger, global strategic plan that Bilim Pharmaceuticals has developed which entails both market entry for several regions and, annually, the addition of 20 products to our portfolio. These products will then become part of our foreign market portfolio. 

Research Interest

 The underlying factors behind our rising sales targets are our concentration on technologically based, R&D activities and the steadily increasing budget allocated for them. Our Research and Development Center has been equipped with more than 220 high-tech machinery units, apparatus and equipment. Our R&D budget, which has been growing incrementally for many years, was even raised from 2009 to 2012, when economic measures had to be taken by pushing through significant cuts in drug sale prices. The budget was maintained at 5% of our net sales.